Terms: = Breast cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Diagnosis
5 results:
1. Plasma microRNA-195, -34c, and - 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients.
Rezaei Z; Dastjerdi K; Allahyari A; ShahidSales S; Talebian S; Maharati A; Zangooie A; Zangouei AS; Sadri F; Sargazi S
Toxicol Appl Pharmacol; 2023 Sep; 475():116652. PubMed ID: 37557922
[TBL] [Abstract] [Full Text] [Related]
2. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
[TBL] [Abstract] [Full Text] [Related]
3. Diet and lifestyle factors interact with MAPK genes to influence survival: the breast cancer Health Disparities Study.
Slattery ML; Hines LH; Lundgreen A; Baumgartner KB; Wolff RK; Stern MC; John EM
Cancer Causes Control; 2014 Sep; 25(9):1211-25. PubMed ID: 24993294
[TBL] [Abstract] [Full Text] [Related]
4. Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
Wishart GC; Greenberg DC; Britton PD; Chou P; Brown CH; Purushotham AD; Duffy SW
Br J Cancer; 2008 Jun; 98(11):1741-4. PubMed ID: 18506175
[TBL] [Abstract] [Full Text] [Related]
5. Genetic basis of human breast cancer metastasis.
Debies MT; Welch DR
J Mammary Gland Biol Neoplasia; 2001 Oct; 6(4):441-51. PubMed ID: 12013533
[TBL] [Abstract] [Full Text] [Related]
